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ABSTRACT
Introduction: Subhyaloidhemorrhage,whether
spontaneous or in the context of a Valsalva
maneuver, can lead to an acute decrease in vision
when located in the premacular region. Nd:YAG
laser hyaloidotomy (NYLH) is a minimally
invasive treatment option.
Methods: We examined two different clinical
courses based on two case reports of NYLH. One
case report described a 52-year-old female
patient who presented with a painless decrease
of vision to 20/200. The fundoscopy verified a
subhyaloid premacular hemorrhage. The
precipitating event for the hemorrhage could
not be determined, and a NYLH was performed
5 days after the event. The other patient was a
48-year-old man who suffered an acute visual
decrease (hand motion) after developing a
migraine with vomiting. Fundoscopy showed a
dense subhyaloid premacular hemorrhage.
NYLH was performed 1 day after the
hemorrhage. These clinical courses were
documented based on fundus photographs,
ultrasounds, and spectral-domain optical
coherence tomography (SD-OCT).
Results: In both cases, there was an effect with
approximately 2.2 mJ of laser energy. In the
female patient, we observed a gradual but
constant increase in vision. After 4 weeks, her
vision improved to 20/20. In the male patient,
the vision increased to 25/20 1 day after
treatment. However, his vision returned to
hand motion as he developed a diffuse
vitreous opacification. Because of delayed
reabsorption, vitrectomy was considered. Since
the optical axis was clear with good vision, we
decided against this surgery. Complete
reabsorption took more than 3 months.
Conclusion: After NYLH for subhyaloid
hemorrhage, pronounced vitreous body
opacification could develop despite a rapid
increase in vision, and requires close
monitoring by the surgeon. Fundus
photography and SD-OCT are suitable means
for clinical course evaluations.
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INTRODUCTION
Subhyaloid premacular hemorrhage usually
leads to an acute and pronounced decrease in
vision. Different mechanisms including
vasoproliferative diseases (e.g., ischemic retinal
venous thromboses or diabetic retinopathy),
vascular anomalies (e.g., retinal
macroaneurysms), or rare pathologies such as
leukemia or Terson syndrome may cause these
hemorrhages [1–4]. A Valsalva maneuver may
also be a typical trigger, because an increase in
intraabdominal/intrathoracic pressure may
result in an increase in cranial pressure and
consequently, an increase in intraocular venous
pressure [5]. The absence of venous valves in the
head/neck area favors this occurrence. Each
mechanism could lead to a bleeding into the
vitreoretinal interface. Due to a still attached
posterior hyaloid membrane, a premacular
hemorrhagic bubble will be formed leading to
a decreased vision and/or a central scotoma.
The visual acuity may decrease to the level of
light perception [4]. Spontaneous reabsorption
is possible. However, the time course is unclear.
Preretinal bleeding can lead to the formation of
epiretinal membranes [2], and there may also be
changes in the retinal pigment epithelium or
damage to the photoreceptors from the iron
ions [3, 6]. For this reason, prompt removal of
the hemorrhage is important [7]. Various
therapeutic approaches may be used, such as
the intravitreal administration of SF6 gas or a
pars plana vitrectomy [8–10]. Opening the
posterior hyaloid membrane by laser (referred
to as membranotomy) presents a minimally
invasive option that had been previously
described in the 1970s [11].
CASE REPORT 1
History and Findings
A 52-year-old female patient presented with an
acute, painless decrease of vision in the right
eye of 4 days duration. A history of a Valsalva
maneuver could not be identified. The woman
had been performing light physical labor in her
garden when she suddenly noticed the
deterioration in vision.
The best corrected visual acuity in the right
eye was 20/200 and in the left eye 20/20. The
patient was myopic (spherical equivalent in the
right eye: -5.5 D; left eye: -6.5 D). There were
no signs of other ophthalmological disorders.
Ophthalmoscopy could detect a moderately
pronounced subhyaloid hemorrhage in the
right eye; however, no other pathologic
findings were detected. The patient had
arterial hypertension but was generally in
good health.
After discussion of the therapeutic options
(observation vs. surgical intervention), the
patient requested immediate treatment.
A Nd:YAG laser hyaloidotomy (NYLH) was
offered. Before treatment, the findings were
documented via fundus photography (Fig. 1a)
and spectral-domain optical coherence
tomography (SD-OCT). The SD-OCT assessed
the accumulated blood in the premacular space
separated by the posterior hyaloid membrane
(Fig. 1b, c).
Therapy
A Q-switched, neodymium-doped yttrium
aluminum garnet (Y3Al5O12) laser (Nd:YAG
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laser, 1064 nm; Visulas IIplus, Zeiss,
Oberkochen, Germany) was used for the
procedure. The laser had a pulse duration of
2–3 ns with a spot size of 10 lm. The four-point
aiming beam system was adjusted for an
anterior focus. This was meant to prevent
damage to the retina from the generated
shockwave. The Area Centralis (Volk Optical
Inc., Mentor, OH, USA) was used as the contact
lens, because it allowed for good visualization of
the central fundus up to the border of the
temporal vessel arches. The magnification for
laser applications was 0.94. After medical
mydriasis and topical anesthesia of the
conjunctiva, we started at an energy level of
1.2 mJ. The laser was employed just above the
inferior apex of the bleeding. With this process,
we observed no effects at the hyaloid
membrane. With increased energy, the blood
bubble started to undulate. A rupture was
finally achieved at 2.2 mJ. Immediately, the
blood slowly started to spread into the
vitreous body space. The cumulative energy
used was 8.9 mJ.
Fig. 1 Central fundus at ﬁrst visit. a Fundus photography:
typical ‘‘blood level’’ in the area of the inferior temporal vascular
arch. b Infrared photograph (green line marks the respective
localization of the SD-OCT image of the c). c Spectral-domain
optical coherence tomography shows a subhyaloid accumulation
of blood. The macula shows a normal conﬁguration
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Clinical Course
After 3 days, the best corrected vision in the right
eye was 0.5. The subhyaloid premacular
hemorrhage was barely detectable on fundoscopy
(Fig. 2a). Blood streaks identified the area of
rupture from the laser (Fig. 2b). The SD-OCT was
able to detect the remaining hemorrhage (Fig. 2c).
Four weeks after treatment, the vision had
increased to 20/20. Residual blood could still
Fig. 2 Inferior temporal vascular arch 3 days after laser
treatment. a Fundus photography shows a reduction in the
premacular hemorrhage as well as remaining streaks of
blood at the inferior temporal vessel arch. b Magniﬁed
fundus photograph with representation of the hyaloidotomy
(red circle). c Spectral-domain optical coherence tomography
of the macula: clear reduction of the subhyaloid opaciﬁcation
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be found in the area of the lower vascular
arch (Fig. 3a). The SD-OCT could barely
detect an opacification of the premacular
space (Fig. 3b). At the site of the laser
application, there was an opening of
399 lm (Fig. 3c).
CASE REPORT 2
History and Findings
A 48-year-old male patient presented with an
acute reduction of vision in his left eye 1 day
Fig. 3 Central fundus 4 weeks after laser treatment.
a Fundus photography: discrete bleeding remained within
the area of the inferior temporal vascular arch (the lines
mark the respective localizations of the SD-OCT images of
the b and c. b SD-OCT of the macula: no subhyaloid
opaciﬁcations were detectable. c SD-OCT of the
hyaloidotomy: a 399-lm rupture of the posterior hyaloid
membrane is recognizable. SD-OCT spectral-domain
optical coherence tomography
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after an episode of severe vomiting due to a
migraine attack. During this episode, the
patient performed several strong Valsalva
maneuvers. Best corrected visual acuity in the
right eye was 25/20. His visual acuity in the left
eye was hand motion at presentation. A dense
and prominent subhyaloid premacular
hemorrhage was seen on ocular examination.
Otherwise, there were no pathological changes.
After appropriate discussion of options, risks,
and benefits, the patient elected to undergo an
NYLH.
Therapy
The procedure was performed in the same way
as described for the first case report. However, in
this patient, no laser effect could initially be
seen with a low-energy setting. After a gradual
increase in energy, a rupture in the posterior
vitreous cortex was observed. The energy
amounted to 2.4 mJ. Altogether, 12.3 mJ was
used.
Clinical Course
On the first post-operative day, the vision had
increased to 25/20. However, the patient
reported a visual deterioration 1 week later. At
this time, the visual acuity had decreased to
hand motion. The subhyaloid blood masses had
drained into the intravitreal cavity and had led
to a diffuse opacification of the vitreous body
(Fig. 4a–c). Because of delayed reabsorption,
vitrectomy was considered. Since the optical
axis was clear with good vision, we decided
against this surgery. Over the next 4 weeks, the




All procedures were in accordance with the
ethical standards of the responsible committee
on human experimentation (institutional and
national) and with the Helsinki Declaration of
1964, as revised in 2013. Informed consent was
obtained from the patients for being included in
the study.
DISCUSSION
Subhyaloid hemorrhage has been defined as
bleeding into the vitreoretinal interface [7]. A
premacular location worsens the clinical picture
for the patient, and leads to an acute painless
decrease in vision or a central scotoma. This
bleeding usually develops in the context of
retinal vasoproliferative disorders, such as
venous thromboses or proliferative diabetic
retinopathy [12, 13]. However, vascular
malformations, Valsalva maneuvers, or
traumata are also possible causes [13]. Terson
syndrome or hematological disorders should
also be considered in the differential diagnosis,
since these may represent acute life-threatening
situations [14, 15].
With our female patient (see ‘‘Case Report
1’’), this hemorrhage was likely a spontaneous
(idiopathic) hemorrhage. Apart from myopia,
she did not have any other causal factors. A
typical Valsalva maneuver could not be
determined from the history. It is possible that
the initial physiological separation of the
posterior vitreous body could have led to a
type of rhexis bleeding from the smallest retinal
vessels. Idiopathic mechanisms should be
considered in the differential diagnosis [4].
The connections between the posterior
vitreous membrane and the inner limiting
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membrane (Membrana limitans interna, MLI) can
be very tough due to the anchoring fibrils
(collagen II, hyalocytes$ fibronectin,
laminin$ collagen IV of the MLI) and can
cause traction [16]. The second case report
concerned a classic Valsalva maneuver that
triggered the bleeding. In contrast to the other
case report, this patient suffered a much
stronger subhyaloid hemorrhage. After
draining the blood into the vitreous cavity, a
severe decrease in visual acuity occurred. The
patient should be consented for a possible delay
of visual recovery.
The treatment of subhyaloid hemorrhage
may include waiting for spontaneous
absorption, vitreal injection of rt-PA
(recombinant tissue plasminogen activator)
with gas, pars plana vitrectomy, or laser
application (argon or Nd:YAG laser) [8–10, 13,
17]. Depending on the application (type of laser
Fig. 4 Image documentations 1 week after surgery.
a Fundus photography: streaky intravitreal blood can be
detected that originated from the inferior temporal vascular
arch. b Ultrasound B image: hemorrhage with subhyaloidal
and intravitreal portions. c Infrared image: in the area of
the laser application, a rupture of approximately 747 lm in
size is seen; green line shows the localization of the
SD-OCT image of Fig. 5d. d SD-OCT of the foveal region:
a dense subhyaloidal hemorrhage is recognizable, and the
retina appears to be normal. SD-OCT spectral-domain
optical coherence tomography
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and contact lens), the use of cumulative
energies of up to 180 mJ has been described
[18]. It is important that optimal conditions are
present during this treatment. The patient must
be cooperative, and the surgeon should be sure
to obtain sufficient medical mydriasis. This
reduces the danger of incident light
dispersion, such as via the iris. Moreover, the
viewing conditions for the surgeon can be
improved. The laser beam should be directed
through the center of the pupil, and a pupil
width of at least 6 mm is necessary. Thereby, the
needed energy can be reduced [4, 18].
NYLH in the context of subhyaloid
hemorrhage represents a minimally invasive
treatment option. It leads to a rapid increase
in vision and is an inexpensive method of
intervention. Complications have rarely been
described. However, retinal defects as well as
vitreal, intraretinal or subretinal and choroidal
hemorrhages can occur [19–21]. Successfully
applied, the subhyaloid hemorrhage drains
into the vitreous body area, where it is
optically less relevant and is better accessible
for reabsorption. With a wait-and-see
procedure, a convalescence of several months
may be expected [4].
CONCLUSIONS
NYLH offers numerous advantages. The
possibility of a rapid increase in vision (if no
other macular pathologies present), the low rate
of complications, the good availability, and low
costs make laser hyaloidotomy a good
treatment option for subhyaloid premacular
hemorrhage. Nevertheless, certain
circumstances should be considered. Serious
underlying diseases should be excluded, and
an optimal environment for the treatment is
Fig. 5 Development of visual acuity over the course of time
after hyaloidotomy. Operation at time t0; afterwards, visual
acuity increased rapidly. After approximately 1 week, the
visual acuity dropped again to hand motions (HM), since
the blood had drained into the vitreous body space. In the
further 4 weeks, constant reabsorption of the blood with a
corresponding increase in vision was seen. The presumed
initial vision of 25/20 was only reached after approximately
3 months
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required. In cases of an observational approach
to the findings, 3 months should not be
exceeded. Modern OCT technology is
exceptionally suited for diagnosis and
evaluation during the clinical course.
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